Search research articles
Contact Us
Filters
Showing results (101-110 of 178) with videos related to
Page
of 18
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2022
Bevacizumab May Differentially Improve Prognosis of Advanced Ovarian Cancer Patients with Low Expression of VEGF-A165b, an Antiangiogenic VEGF-A Splice Variant
Pauline Wimberger, Mara Julia Gerber, Jacobus Pfisterer, et al.
Gynecologic Oncology
|
January 8, 2016
BRCA1/2 mutations associated with progression-free survival in ovarian cancer patients in the AGO-OVAR 16 study
Philipp Harter, Toby Johnson, Dominique Berton-Rigaud, et al.
Gynecologic Oncology
|
August 28, 2024
Reproductive outcomes after fertility-sparing surgery for cervical cancer - results of the multicenter FERTISS study
Lenka Fricová, Stefan Kommoss, Giovanni Scambia, et al.
Gynecologic Oncology
|
June 4, 2024
Efficacy and safety of niraparib in patients aged 65 years and older with advanced ovarian cancer: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial
Giorgio Valabrega, Bhavana Pothuri, Ana Oaknin, et al.
Cancer Causes & Control : CCC
|
January 5, 2017
Predictors of pretreatment CA125 at ovarian cancer diagnosis: a pooled analysis in the Ovarian Cancer Association Consortium
Ana Babic, Daniel W Cramer, Linda E Kelemen, et al.
Oncogene
|
November 9, 2023
Shallow whole genome sequencing approach to detect Homologous Recombination Deficiency in the PAOLA-1/ENGOT-OV25 phase-III trial
Celine Callens, Manuel Rodrigues, Adrien Briaux, et al.
Gynecologic Oncology
|
February 7, 2024
Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo: Results from the phase 3 randomized PRIMA/ENGOT-OV26/GOG-3012 trial
Bhavana Pothuri, Sileny Han, Dana M Chase, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 19, 2023
The KORE-INNOVATION trial, a prospective controlled multi-site clinical study to implement and assess the effects of an innovative peri-operative care pathway for patients with ovarian cancer: rationale, methods and trial design
Melisa Guelhan Inci, Jalid Sehouli, Eva Schnura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2019
Dilution of Molecular-Pathologic Gene Signatures by Medically Associated Factors Might Prevent Prediction of Resection Status After Debulking Surgery in Patients With Advanced Ovarian Cancer
Florian Heitz, Stefan Kommoss, Roshan Tourani, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 6, 2022
Maintenance olaparib plus bevacizumab in patients with newly diagnosed advanced high-grade ovarian cancer: Main analysis of second progression-free survival in the phase III PAOLA-1/ENGOT-ov25 trial
Antonio González-Martín, Christophe Desauw, Florian Heitz, et al.
Page
of 18
Search research articles
Search
Showing results (101-110 of 178) with videos related to
Sort By:
Page
of 18
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2022
Bevacizumab May Differentially Improve Prognosis of Advanced Ovarian Cancer Patients with Low Expression of VEGF-A165b, an Antiangiogenic VEGF-A Splice Variant
Pauline Wimberger, Mara Julia Gerber, Jacobus Pfisterer, et al.
Gynecologic Oncology
|
January 8, 2016
BRCA1/2 mutations associated with progression-free survival in ovarian cancer patients in the AGO-OVAR 16 study
Philipp Harter, Toby Johnson, Dominique Berton-Rigaud, et al.
Gynecologic Oncology
|
August 28, 2024
Reproductive outcomes after fertility-sparing surgery for cervical cancer - results of the multicenter FERTISS study
Lenka Fricová, Stefan Kommoss, Giovanni Scambia, et al.
Gynecologic Oncology
|
June 4, 2024
Efficacy and safety of niraparib in patients aged 65 years and older with advanced ovarian cancer: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial
Giorgio Valabrega, Bhavana Pothuri, Ana Oaknin, et al.
Cancer Causes & Control : CCC
|
January 5, 2017
Predictors of pretreatment CA125 at ovarian cancer diagnosis: a pooled analysis in the Ovarian Cancer Association Consortium
Ana Babic, Daniel W Cramer, Linda E Kelemen, et al.
Oncogene
|
November 9, 2023
Shallow whole genome sequencing approach to detect Homologous Recombination Deficiency in the PAOLA-1/ENGOT-OV25 phase-III trial
Celine Callens, Manuel Rodrigues, Adrien Briaux, et al.
Gynecologic Oncology
|
February 7, 2024
Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo: Results from the phase 3 randomized PRIMA/ENGOT-OV26/GOG-3012 trial
Bhavana Pothuri, Sileny Han, Dana M Chase, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 19, 2023
The KORE-INNOVATION trial, a prospective controlled multi-site clinical study to implement and assess the effects of an innovative peri-operative care pathway for patients with ovarian cancer: rationale, methods and trial design
Melisa Guelhan Inci, Jalid Sehouli, Eva Schnura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2019
Dilution of Molecular-Pathologic Gene Signatures by Medically Associated Factors Might Prevent Prediction of Resection Status After Debulking Surgery in Patients With Advanced Ovarian Cancer
Florian Heitz, Stefan Kommoss, Roshan Tourani, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 6, 2022
Maintenance olaparib plus bevacizumab in patients with newly diagnosed advanced high-grade ovarian cancer: Main analysis of second progression-free survival in the phase III PAOLA-1/ENGOT-ov25 trial
Antonio González-Martín, Christophe Desauw, Florian Heitz, et al.
Page
of 18